Liu Tao, Qian Wei-Jun, Mottaz Heather M, Gritsenko Marina A, Norbeck Angela D, Moore Ronald J, Purvine Samuel O, Camp David G, Smith Richard D
Biological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, USA.
Mol Cell Proteomics. 2006 Nov;5(11):2167-74. doi: 10.1074/mcp.T600039-MCP200. Epub 2006 Jul 19.
Strategies for removal of high abundance proteins have been increasingly utilized in proteomic studies of serum/plasma and other body fluids to enhance the detection of low abundance proteins and achieve broader proteome coverage; however, both the reproducibility and specificity of the high abundance protein depletion process still represent common concerns. Here we report a detailed evaluation of immunoaffinity subtraction performed applying the ProteomeLab IgY-12 system that is commonly used in human serum/plasma proteome characterization in combination with high resolution LC-MS/MS. Plasma samples were repeatedly processed using this approach, and the resulting flow-through fractions and bound fractions were individually analyzed for comparison. The removal of target proteins by the immunoaffinity subtraction system and the overall process was highly reproducible. Non-target proteins, including one spiked protein standard (rabbit glyceraldehyde-3-phosphate dehydrogenase), were also observed to bind to the column at different levels but also in a reproducible manner. The results suggest that multiprotein immunoaffinity subtraction systems can be readily integrated into quantitative strategies to enhance detection of low abundance proteins in biomarker discovery studies.
在血清/血浆及其他体液的蛋白质组学研究中,去除高丰度蛋白质的策略已越来越多地被采用,以提高低丰度蛋白质的检测率并实现更广泛的蛋白质组覆盖范围;然而,高丰度蛋白质去除过程的重现性和特异性仍是人们普遍关注的问题。在此,我们报告了对应用ProteomeLab IgY - 12系统进行免疫亲和扣除法的详细评估,该系统常用于人类血清/血浆蛋白质组表征,并结合了高分辨率液相色谱 - 串联质谱(LC - MS/MS)。使用这种方法对血浆样本进行反复处理,并分别分析所得的流穿组分和结合组分以作比较。免疫亲和扣除系统对目标蛋白质的去除以及整个过程具有高度的重现性。还观察到非目标蛋白质,包括一种添加的蛋白质标准品(兔甘油醛 - 3 - 磷酸脱氢酶),也会以不同程度但同样可重现的方式与柱子结合。结果表明,多蛋白免疫亲和扣除系统可轻松整合到定量策略中,以增强生物标志物发现研究中低丰度蛋白质的检测。